Michael Harry Rosenthal serves as Executive at ENTELLUS MEDICAL INC, where they oversee executive responsibilities. Since joining the company, Michael Harry Rosenthal has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 28, 2018 involved selling 30,000 shares valued at $720.0K.
Michael Harry Rosenthal currently holds 30,000 shares of ENTELLUS MEDICAL INC (ENTL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Harry Rosenthal has been a net neutral trader of ENTL stock. They have purchased $0 and sold $0 worth of shares.
Michael Harry Rosenthal's most recent insider trade was on Feb 28, 2018, when they sold 30,000 shares at $24.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 4, 2017 | ENTL | $0 | Award | 20,000 | $N/A | Discretionary |